Skip to main content

Want a detailed portfolio tracker?

Nuvation Bio (NUVB) P/E (2021 - 2026)

Nuvation Bio (NUVB) P/E from Mar 31, 2021 to Jun 3, 2026. The TTM Nuvation Bio (NUVB) P/E is -10.98. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Nuvation Bio (NUVB)

YearP/EChange
2026-10.98-26.10%
2025-14.86+1127.05%
2024-1.21-69.63%
2023-3.99+3.26%
2022-3.86-81.88%
2021-21.32N/A

Comparison Nuvation Bio (NUVB) P/E with competitors

Nuvation Bio (NUVB) P/E is -10.98.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.10-100.93%
ENLVEnlivex Therapeutics Ltd0.15-101.37%
FGENFibroGen Inc0.24-102.19%
TRAWTraws Pharma Inc0.47-104.31%
FBIOFortress Biotech Inc0.71-106.43%
CHRSCoherus Biosciences Inc0.98-108.91%
ORMPOramed Pharmaceuticals Inc1.47-113.42%
AGENAgenus Inc2.05-118.65%
VIVSVivoSim Labs Inc2.54-123.09%
INVAInnoviva Inc3.19-129.03%
CRMDCorMedix Inc3.65-133.20%
ABEOAbeona Therapeutics Inc4.20-138.29%
VXRTVaxart Inc4.26-138.81%
CVACCureVac N.V.4.45-140.48%
SRPTSarepta Therapeutics Inc4.62-142.11%
GLPGGalapagos NV4.86-144.25%
RIGLRigel Pharmaceuticals4.92-144.80%
ZVRAZevra Therapeutics Inc4.97-145.29%
ABUSArbutus Biopharma Corp5.69-151.85%
CGENCompugen Ltd7.38-167.24%
AUPHAurinia Pharmaceuticals Inc9.25-184.25%
ACADAcadia Pharmaceuticals Inc9.59-187.31%
OMEROmeros Corporation9.88-190.00%
PLXProtalix BioTherapeutics Inc9.91-190.24%
SPROSpero Therapeutics Inc10.73-197.75%
ADMAAdma Biologics Inc11.33-203.18%
SVASinovac Biotech Ltd11.44-204.14%
TBPHTheravance Biopharma Inc11.78-207.24%
HRMYHarmony Biosciences Holdings Inc12.18-210.92%
TGTXTG Therapeutics Inc13.18-220.02%
INCYIncyte Corp13.38-221.86%
SABSSAB Biotherapeutics Inc14.06-228.01%
XOMAXOMA Corp14.95-236.10%
REGNRegeneron Pharmaceuticals Inc14.98-236.41%
PBYIPuma Biotechnology Inc15.05-237.05%
EXELExelixis Inc15.79-243.83%
NAGENiagen Bioscience Inc16.35-248.93%
CPRXCatalyst Pharmaceuticals Inc17.34-257.95%
MDXGMimedx Group Inc17.38-258.23%
ARGXArgen X SE23.07-310.10%
HALOHalozyme Therapeutics Inc23.20-311.27%
XOMAOXOMA Corp25.34-330.80%
VRTXVertex Pharmaceuticals Inc25.66-333.63%
XOMAPXOMA Corp25.67-333.76%
CTMXCytomX Therapeutics Inc25.70-334.01%
ASNDAscendis Pharma A/S26.35-339.99%
RPRXRoyalty Pharma plc - Class A27.50-350.38%
SLNOSoleno Therapeutics Inc29.02-364.22%
LGNDLigand Pharmaceuticals Inc - Class B30.19-374.89%
BMRNBiomarin Pharmaceutical Inc37.51-441.55%
APLSApellis Pharmaceuticals Inc39.02-455.34%
KRYSKrystal Biotech Inc39.70-461.50%
GMABGenmab40.20-466.11%
ONCBeiGene Ltd67.03-710.37%
TECHBio-Techne Corp68.59-724.65%
VCELVericel Corp80.63-834.24%
PHARPharming Group N.V.87.74-898.99%
ALNYAlnylam Pharmaceuticals Inc124.93-1237.69%
TLXTelix Pharmaceuticals Ltd139.89-1373.89%
CORTCorcept Therapeutics Inc158.39-1542.35%